To cite this paper use one of the standards below:
Metabotropic glutamate receptor 5 (mGluR5) is expressed in many brain regions and is involved in many processes such as cerebral plasticity, learning and memory. mGluR5 modulates other receptors such as NMDAR, which is also relevant in pathological contexts like Alzheimer’s disease. Neuronal growth regulator 1 (NEGR1) is an adhesion protein belonging to the immunoglobulin superfamily that is widely expressed in the brain and plays an important role in neuronal arborization and plasticity. Expression defects of NEGR1 have been linked to cognitive and comportamental dysfunctions. Our research group has demonstrated by coimmunoprecipitation experiments that NEGR1 physically interacts with mGluR5. We are now interested in investigating whether NEGR1 can modulate calcium mobilization via mGluR5 activation. We used neuronal cultures (DIV 9) from C57BL/6 mouse embryos. We performed NEGR1 knockdown using a lentivirus containing a shRNA sequence targeting NEGR1 mRNA. As a control, we employed a lentivirus containing a scramble shRNA sequence that does not target any murine mRNA. We used glutamate (endogenous ligand) (50 uM) as stimuli alone or combined with CTEP (10 uM) and MK-801 (50 uM), blockers of mGluR5 and NMDAR respectively. Calcium changes were measured using Fura-2 AM. Calcium variation values were expressed as the average difference between the area under the stimulus curve and the area under the baseline curve. NEGR1 knockdown was able to induce a decrease in calcium mobilization triggered by glutamate stimulation, as compared to cultures infected with control lentivirus (p=0.0175, t test). There was no difference in Ca2+ mobilization between NEGR1 knockdown and control when the receptor was blocked by CTEP and MK-801. Our data suggest that NEGR1 is essential for mGluR5 activation, as its knockdown decreases intracellular calcium mobilization. The data also suggest that NEGR1 could be a potential strategy for mGluR5 modulation in a pathological context.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper